What's Happening?
Researchers at Wageningen University & Research have successfully recreated ancient enzymes from early ancestors of the cannabis plant. These enzymes, which were active millions of years ago, are crucial for the production of cannabinoids like THC, CBD,
and CBC. The study, published in the Plant Biotechnology Journal, demonstrates that these ancestral enzymes are more robust and flexible than their modern counterparts, making them promising candidates for biotechnological applications in medicine.
Why It's Important?
This research could revolutionize the production of cannabinoids, which are increasingly used in medical treatments. By utilizing these ancient enzymes, scientists can potentially produce cannabinoids more efficiently and sustainably through biotechnology, rather than traditional cultivation. This advancement could lead to the development of new medicinal cannabis varieties with specific therapeutic properties, such as high CBC content, which is known for its anti-inflammatory effects. The study also highlights the potential of using ancient DNA to unlock new biotechnological applications.
